Annual General Meeting of Shareholders of Lavipharm S.A.: Strong Financial Performance in 2025, Landmark Acquisition of DUROGESIC® Rights and Dividend Distribution
Posted at h
in Announcements
Paiania, June 25, 2026 – The Annual General Meeting of Shareholders of Lavipharm S.A. (LAVI) was held at the Company’s headquarters in Paiania, with the participation of 39 shareholders representing 75,10 % of the paid-up share capital, thereby securing the required quorum.